Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome

Published:2022-08-01 Issue:6 Volume:20 Page:321-328
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Premji Resmi¹,Nylen Eric S.²,Naser Nejat²,Gandhi Shruti²,Burman Kenneth D.³,Sen Sabyasachi²^ORCID

Affiliation:

1. Montage Medical Group, Monterey, California, USA.

2. Department of Endocrinology, VAMC and George Washington University School of Medicine, Washington, District of Columbia, USA.

3. Department of Endocrinology, Georgetown University School of Medicine, Washington Hospital Center, Washington, District of Columbia, USA.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2022.0004

Reference69 articles.

1. Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

2. Glucagon-like peptide 1 (GLP-1)

3. Cardiovascular Protection with Anti-hyperglycemic Agents

4. Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-renal Effect of Dapagliflozin AND Dapagliflozin- Saxagliptin combination on CD34+ve Hematopoietic Stem Cells (HSCs) and Podocyte specific markers in Type 2 Diabetes (T2DM) subjects: a randomized trial.;2024-08-21

2. Diverse Strategies for Modulating Insulin Resistance: Causal or Consequential Inference on Metabolic Parameters in Treatment-Naïve Subjects with Type 2 Diabetes;Medicina;2024-06-17

3. New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions;International Journal of Molecular Sciences;2024-06-05

4. The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 Diabetes;Annals of Military and Health Sciences Research;2024-05-24

5. Effect of sodium-dependent glucose cotransporter type 2 inhibitors on lipid metabolism in patients with diabetes mellitus (literature review);JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE;2023-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3